Correction to: Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55 (Oncogene, (2008), 27, 54, (6791-6805), 10.1038/onc.2008.291);Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55

Oncogene

Volumn 27, Issue 54, 2008, Pages 6791-6805

  Wang, H ^a   Song, K ^a   Krebs, T L ^a   Yang, J ^a   Danielpour, D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hic 5; Prostate; Smad; Smad2; Smad7; TGF

Indexed keywords

HYDROGEN PEROXIDE INDUCIBLE CLONE 5; LIM PROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL LINE; CELL SPECIFICITY; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 56649106486     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-022-02510-8     Document Type: Erratum

References (59)

1. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
2. Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ et al. (2002a). The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem 277: 1240-1248.
3. Chipuk JE, Stewart LV, Ranieri A, Song K, Danielpour D. (2002b). Identification and characterization of a novel rat ov-serpin family member, trespin. J Biol Chem 277: 26412-26421.
4. Dabiri G, Tumbarello DA, Turner CE, Van De Water L. (2008). Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol (in press).
5. Danielpour D. (2005). Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 41: 846-857.
6. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB. (1994). Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 54: 3413-3421.
7. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ et al. (2002). Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 99: 3908-3913.
8. Durand MK, Bodker JS, Christensen A, Dupont DM, Hansen M, Jensen JK et al. (2004). Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost 91: 438-449.
9. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T et al. (2001). Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477-12480.
10. Edlund S, Bu S, Schuster N, Aspenstrom P, Heuchel R, Heldin NE et al. (2003). Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14: 529-544.
11. Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A et al. (1999). Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Biol Chem 274: 8316-8321.
12. Fujita H, Kamiguchi K, Cho D, Shibanuma M, Morimoto C, Tachibana K. (1998). Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase. J Biol Chem 273: 26516-26521.
13. Gronroos E, Hellman U, Heldin CH, Ericsson J. (2002). Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell 10: 483-493.
14. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW et al. (1997). The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89: 1165-1173.
15. Heitzer MD, DeFranco DB. (2006a). Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. Cancer Res 66: 7326-7333.
16. Heitzer MD, DeFranco DB. (2006b). Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol Endocrinol 20: 56-64.
17. Hong S, Lee C, Kim SJ. (2007). Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res 67: 9577-9583.
18. Horrevoets AJ. (2004). Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance. Br J Haematol 125: 12-23.
19. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375.
20. Kim SG, Kim HA, Jong HS, Park JH, Kim NK, Hong SH et al. (2005). The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 16: 4672-4683.
21. Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A et al. (2003). Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J 22: 6458-6470.
22. Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K et al. (2004). Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Oncogene 23: 6914-6923.
23. Lallemand F, Mazars A, Prunier C, Bertrand F, Kornprost M, Gallea S et al. (2001). Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 20: 879-884.
24. Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G et al. (2005). AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism. J Biol Chem 280: 27645-27653.
25. Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P et al. (2000). Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol 10: 535-538.
26. Massague J, Andres J, Attisano L, Cheifetz S, Lopez-Casillas F, Ohtsuki M et al. (1992). TGF-beta receptors. Mol Reprod Dev 32: 99-104.
27. Massague J, Blain SW, Lo RS. (2000). TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
28. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M et al. (2001). Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 276: 36797-36803.
29. Mori K, Asakawa M, Hayashi M, Imura M, Ohki T, Hirao E et al. (2006). Oligomerizing potential of a focal adhesion LIM protein Hic-5 organizing a nuclear-cytoplasmic shuttling complex. J Biol Chem 281: 22048-22061.
30. Moustakas A, Heldin CH. (2005). Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584.
31. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R et al. (1997). Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635.
32. Nishiya N, Tachibana K, Shibanuma M, Mashimo JI, Nose K. (2001). Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol Cell Biol 21: 5332-5345.
33. Qin XF, An DS, Chen IS, Baltimore D. (2003). Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 100: 183-188.
34. Rahimi RA, Leof EB. (2007). TGF-beta signaling: a tale of two responses. J Cell Biochem 102: 593-608.
35. Rahman MM, Miyamoto H, Lardy H, Chang C. (2003). Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. Proc Natl Acad Sci USA 100: 5124-5129.
36. Shibanuma M, Kim-Kaneyama JR, Ishino K, Sakamoto N, Hishiki T, Yamaguchi K et al. (2003). Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell 14: 1158-1171.
37. Shibanuma M, Mashimo J, Kuroki T, Nose K. (1994). Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269: 26767-26774.
38. Shibanuma M, Mochizuki E, Maniwa R, Mashimo J, Nishiya N, Imai S et al. (1997). Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol Cell Biol 17: 1224-1235.
39. Simonsson M, Heldin CH, Ericsson J, Gronroos E. (2005). The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem 280: 21797-21803.
40. Song K, Cornelius SC, Danielpour D. (2003a). Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Cancer Res 63: 4358-4367.
41. Song K, Cornelius SC, Reiss M, Danielpour D. (2003b). Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 278: 38342-38351.
42. Song K, Krebs TL, Danielpour D. (2006a). Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. J Biol Chem 281: 7765-7774.
43. Song K, Wang H, Krebs TL, Danielpour D. (2006b). Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 25: 58-69.
44. Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Bottinger EP et al. (1999). Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Cancer Res 59: 4834-4842.
45. Thomas SM, Hagel M, Turner CE. (1999). Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J Cell Sci 112(Part 2): 181-190.
46. Tumbarello DA, Turner CE. (2007). Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 211: 736-747.
47. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP. (2000). Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 275: 11320-11326.
48. Wakefield LM, Roberts AB. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
49. Wang H, Song K, Sponseller TL, Danielpour D. (2005). Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J Biol Chem 280: 5154-5162.
50. Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY et al. (2002). Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator. J Biol Chem 277: 15426-15431.
51. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT et al. (2005). The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24: 8080-8084.
52. Wilkes MC, Leof EB. (2006). Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J Biol Chem 281: 27846-27854.
53. Wiznerowicz M, Trono D. (2003). Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77: 8957-8961.
54. Wrana JL, Attisano L. (1996). MAD-related proteins in TGF-beta signalling. Trends Genet 12: 493-496.
55. Wrana JL, Carcamo J, Attisano L, Cheifetz S, Zentella A, Lopez-Casillas F et al. (1992). The type II TGF-beta receptor signals diverse responses in cooperation with the type I receptor. Cold Spring Harb Symp Quant Biol 57: 81-86.
56. Yang J, Song K, Krebs TL, Jackson MW, Danielpour D. (2008). Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression. Oncogene (in press).
57. Yue J, Frey RS, Mulder KM. (1999). Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18: 2033-2037.
58. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y et al. (2007). Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 27: 4488-4499.
59. Zhang Y, Feng X, We R, Derynck R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383: 168-172.